Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
about
Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugsRecent advances and novel treatment paradigms in acute lymphocytic leukemiaSyk and tired of current chronic GVHD therapies.Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote AngiogenesisSyk Is Recruited to Stress Granules and Promotes Their Clearance through Autophagy.Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances.Identification of differentially expressed splice variants by the proteogenomic pipeline Splicify.DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88.DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk.Central role of PI3K-SYK interaction in fibrinogen-induced lamellipodia and filopodia formation in platelets.High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.Kinase-targeted cancer therapies: progress, challenges and future directions.Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma.Phosphorylated immunoreceptor tyrosine-based activation motifs and integrin cytoplasmic domains activate spleen tyrosine kinase via distinct mechanisms.Alternative Splicing as a Target for Cancer Treatment.Suppression of Spleen Tyrosine Kinase (Syk) by Histone Deacetylation Promotes, Whereas BAY61-3606, a Synthetic Syk Inhibitor Abrogates Colonocyte Apoptosis by ERK Activation.SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.Lymphatics-associated genes are downregulated at transcription level in non-small cell lung cancer.Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays.KISS1/KISS1R in Cancer: Friend or Foe?
P2860
Q27726998-F8995634-A7FB-45B6-A494-F95DC893F498Q28078076-1E3B9AF9-F37C-4C4F-B3EA-8B5EAF80C014Q35784487-B720F8DB-39B1-47E5-8025-EB85F37E5E6FQ36281674-CCBFDB59-9A89-4264-A4D3-579C85C2B2F3Q36282920-55129A5A-8777-4B88-8D57-7621A766D34EQ38554422-8BDEC252-6442-4B2D-85EF-92A4EDBF961AQ38659439-E8C6E82C-47FD-49DB-BF48-62D7D443B923Q38743845-73A68A8C-14FF-48DA-B56A-129A5D89B935Q40410579-DCE38EA6-148D-4AD7-AF1A-8757E0A43135Q41199050-9402B917-529F-43A8-90E0-36DE4E7927B5Q41779379-D6FC0EED-12BF-4F3E-BCB7-ACA2427692C2Q42366278-5AD25546-E8AC-4C71-A731-28D3BBD1E501Q49887882-3FA2748E-3D7C-4671-85D9-E54C8F6CD1DAQ49887894-906CDBBA-DA95-4216-A19E-7AE40311619EQ49952999-3367123E-3F74-4CD5-AF10-91C79217D260Q50027146-2EE6B2F1-0767-4818-A0A6-1CF90B661205Q50033988-F3C6CFA5-C443-4772-AE2A-740B717563D8Q51706615-7B58B396-1FBF-49B2-A5AF-500837AB9DB7Q52699628-305C2E0D-3DC2-4805-B5DB-4D6CF3EE06A3Q54977595-2CB6F4DB-B11D-42B4-92EB-03CB67E74F40Q54979889-247629DA-11A5-4F08-A727-BC25B2DAEE31Q57170895-CB47D9E1-AF2F-4AD9-A48B-687497401C96
P2860
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
@ast
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
@en
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
@nl
type
label
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
@ast
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
@en
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
@nl
prefLabel
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
@ast
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
@en
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
@nl
P2860
P1476
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer
@en
P2093
Mariya O Krisenko
P2860
P304
P356
10.1016/J.BBAMCR.2014.10.022
P407
P577
2014-11-04T00:00:00Z